Skip to content

The effect of magnet therapy in the treatment of patients with shoulder impingement syndrome

Evaluation of the effect of electromagnetic therapy to reduce pain and disability in patients with shoulder impingement syndrome

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210424051069N1
Enrollment
60
Registered
2021-05-30
Start date
2021-06-10
Completion date
Unknown
Last updated
2021-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder impingement syndrome. Impingement syndrome of shoulder

Interventions

Intervention 1: The first intervention group: magnet therapy with a frequency of 18 Hz, Magnet therapy is 12 sessions, 3 times a week for 4 weeks. The magnitude of the magnet is 100 mT and the duratio

Sponsors

Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients who have pain in the shoulder joint for at least one month. There should be restrictions on at least one active shoulder movement (flexion, abduction, external and internal rotation). Participants are in the age range of 20 to 60 years. Get an initial DASH score of more than 45%.

Exclusion criteria

Exclusion criteria: Participants with neurological disorders. Participants with injuries to the neck, elbows or hands. Participants with rheumatoid arthritis. Participants with heart disease. Participants who have a history of previous upper limb surgery. Women who are pregnant. People who have received intra-articular anti-inflammatory drugs in the last 60 days. Participants with pathological shoulder disorders such as hooked acromion, osteoarthritis, adhesive capsulitis or traumatic labrum tears.

Design outcomes

Primary

MeasureTime frame
Pain, disability, shoulder range of motion. Timepoint: Measurement of pain, disability and shoulder range of motion at the beginning of the study (before the intervention) and after the end of treatment sessions (12th session). Method of measurement: Visual Analogue Scale; Disabilities of the Arm, Shoulder and Hand questionnaire; Goniometer.

Secondary

MeasureTime frame
Gender, age, height, weight, occupation, hand dominance. Timepoint: Before the intervention. Method of measurement: Questionnaire, meter, Weighing scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Mirali Eterafoskouei

Tabriz University of Medical Sciences

Eterafoskouei@tbzmed.ac.ir+98 41 3337 2072

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026